Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670253 | SCV000795086 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-10-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000680438 | SCV000807809 | likely pathogenic | Usher syndrome type 2A | 2018-03-10 | criteria provided, single submitter | clinical testing | This variant deletes one nucleotide resulting in an amino acid alteration, replacing a serine (S) with a methionine (M) at codon 2498 creating a premature stop signal in the new reading frame noted as p.S2498Mfs*30. The substitution is predicted to result in a non-functional USH2A protein, either through protein truncation or nonsense-mediated mRNA decay. This mutation is considered a non-tolerated amino acid change based on in silico prediction algorithms (disease causing), and it has not been reported in the Clinical Variant Database (NCBI National Library of Medicine, NIH) or in population databases such as ExAC or 1000G. Based on these findings and the limited literature regarding this substitution we consider it as a likely pathogenic variant. |
Labcorp Genetics |
RCV001234813 | SCV001407473 | pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser2498Metfs*30) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with autosomal recessive retinitis pigmentosa or Usher syndrome type II (PMID: 18641288, 20507924). ClinVar contains an entry for this variant (Variation ID: 554589). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003453296 | SCV004183244 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000680438 | SCV004183245 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003453296 | SCV004208372 | pathogenic | Retinitis pigmentosa 39 | 2023-07-27 | criteria provided, single submitter | clinical testing |